ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products.

October 8, 2004

DCT Board Approves Concepts For Three Radiation Research RFAs

March 6, 1987

UICC Announces Four Fellowship Program

April 22, 1983

Cancer Control: Incidence, Death Rates Continue To Fall, Annual Reports Says

April 23, 1999

BRMP Workshops Planned; DCT Board Balk At Size of Intramural Budget

November 28, 1980

Managed Care: “Natural Alliance” Between Managed Care And Academic Centers, McGivney Says

January 24, 1997